Sfoglia per Autore
Shortened interval of octreotide LAR administration is effective in patients with well differentiated neuroendocrine carcinomas in progression on standard doses.
2011 Ferolla, Piero; Faggiano, A; Grimaldi, F; Ferone, D; Scarpelli, Giovanni; Ramundo, V; Severino, R; Bellucci, Mc; Camera, Lm; Lombardi, G; Angeletti, G; Colao, A.
(111)In-pentetreotide SPET/CT in carcinoid tumours: is the role of hybrid systems advantageous in abdominal or thoracic lesions?
2011 Tranfaglia, Cristina; Cardinali, Laura; Gattucci, Maurizio; Scialpi, Michele; Ferolla, Piero; Sinzinger, H; Palumbo, Barbara
Lack of Accuracy of Circulating Chromogranin A in the Preoperative Diagnosis of Lung Neuroendocrine Tumors
2012 Scarpelli, G; Daddi, Niccolo'; Maiettini, D; Pascucci, C; Minotti, V; Puma, Francesco; Crino', Lucio; Ferolla, Piero
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses.
2012 Ferolla, Piero; Faggiano, A; Grimaldi, F; Ferone, D; Scarpelli, Giovanni; Ramundo, V; Severino, R; Bellucci, Mc; Camera, Lm; Angeletti, Gabriella; Angeletti, G; Colao, A.
Long-term survival and prognostic factors in neuroendocrine tumors: Results from a large multicenter study
2012 Faggiano, A; Grimaldi, F; Manzoni, M; Davi, Mv; Ferone, D; Giuffrida, D; Roiter, I; Fanciulli, G; Papini, E; Martini, C; Franchi, Gm; Fasola, G; Albertelli, M; Crino', Lucio; Colao, A; Ferolla, Piero
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: THE NET MANAGEMENT STUDY
2012 Faggiano, A; Ferolla, Piero; Grimaldi, F; Campana, D; Manzoni, M; Davi, Mv; Bianchi, A; Valcavi, R; Papini, E; Giuffrida, D; Ferone, D; Fanciulli, G; Arnaldi, G; Franchi, Gm; Francia, G; Fasola, G; Crino', Lucio; Pontecorvi, L; Tomassetti, P; Colao, A.
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study
2012 Faggiano, A; Ramundo, V; Dicitore, A; Castiglioni, S; Borghi, Mo; Severino, R; Ferolla, Piero; Crino', Lucio; Abbruzzese, A; Sperlongano, P; Caraglia, M; Ferone, D; Hofland, L; Colao, A; Vitale, G.
Evaluation of the different role of 111 In -pentetreotide SPECT/CT of thorax and abdomen in investigating carcinoid tumours
2013 Buresta, Tommaso; I., Sabalich; Ferolla, Piero; Tranfaglia, Cristina; Fazzi, Giuseppina; Palumbo, Barbara
Comorbilità di ansia e depressione nei pazienti con tumori carcinoidi - Comorbility between anxiety and depression in patients with carcinoid tumors -
2013 Moretti, Patrizia; Dennis, J. L.; Stella, Aldo; Alpini, A.; Cotichelli, P.; Ferolla, Piero; Scarpelli, Giovanni; Quartesan, Roberto; Piselli, M.
LA TERAPIA DEI PROLATTINOMI IN TEMPO DI SPENDING REVIEW. BROMOCRIPTINA vs CABERGOLINA: ANALISI COSTO-EFFICACIA
2014 Posati, G.; Carnevale, D.; Scarpelli, Giovanni; Ferolla, Piero; Bini, Vittorio; Angeletti, Gabriella
Postsurgical follow-up is always necessary in bronchial carcinoid
2014 Ferolla, Piero; Daddi, N; Puma, Francesco; Crino', Lucio
Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice
2016 Metro, Giulio; Ricciuti, Biagio; Chiari, Rita; Baretti, Marina; Falcinelli, Lorenzo; Giannarelli, Diana; Sidoni, Angelo; Mountzios, Giannis; Crino', Lucio; Bellezza, Guido; Rebonato, Alberto; Ferolla, Piero; Toschi, Luca
Effect of EPA on Neonatal Pig Sertoli Cells “In Vitro”: A Possible Treatment to Help Maintain Fertility in Pre-Pubertal Boys Undergoing Treatment With Gonado-Toxic Therapies
2021 Arato, I.; Ceccarelli, V.; Mancuso, F.; Bellucci, C.; Lilli, C.; Ferolla, P.; Perruccio, K.; D'Arpino, A.; Aglietti, M. C.; Calafiore, R.; Cameron, D. F.; Calvitti, M.; Baroni, T.; Vecchini, A.; Luca, G.
Prognostic Significance of Pulmonary Multifocal Neuroendocrine Proliferation With Typical Carcinoid
2022 Tassi, V.; Scarnecchia, E.; Ferolla, P.; Mete, O.; Manjula, M.; Allison, F.; Potenza, R.; Vannucci, J.; Ceccarelli, S.; Yasufuku, K.; De Perrot, M.; Pierre, A.; Darling, G.; Colella, R.; Ascani, S.; Mattioli, S.; Keshavjee, S.; Waddell, T. K.; Puma, F.; Daddi, N.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Shortened interval of octreotide LAR administration is effective in patients with well differentiated neuroendocrine carcinomas in progression on standard doses. | 2011 | Ferolla, Piero; Faggiano, A; Grimaldi, F; Ferone, D; Scarpelli, Giovanni; Ramundo, V; Severino, R; Bellucci, Mc; Camera, Lm; Lombardi, G; Angeletti, G; Colao, A. | |
| (111)In-pentetreotide SPET/CT in carcinoid tumours: is the role of hybrid systems advantageous in abdominal or thoracic lesions? | 2011 | Tranfaglia, Cristina; Cardinali, Laura; Gattucci, Maurizio; Scialpi, Michele; Ferolla, Piero; Sinzinger, H; Palumbo, Barbara | |
| Lack of Accuracy of Circulating Chromogranin A in the Preoperative Diagnosis of Lung Neuroendocrine Tumors | 2012 | Scarpelli, G; Daddi, Niccolo'; Maiettini, D; Pascucci, C; Minotti, V; Puma, Francesco; Crino', Lucio; Ferolla, Piero | |
| Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses. | 2012 | Ferolla, Piero; Faggiano, A; Grimaldi, F; Ferone, D; Scarpelli, Giovanni; Ramundo, V; Severino, R; Bellucci, Mc; Camera, Lm; Angeletti, Gabriella; Angeletti, G; Colao, A. | |
| Long-term survival and prognostic factors in neuroendocrine tumors: Results from a large multicenter study | 2012 | Faggiano, A; Grimaldi, F; Manzoni, M; Davi, Mv; Ferone, D; Giuffrida, D; Roiter, I; Fanciulli, G; Papini, E; Martini, C; Franchi, Gm; Fasola, G; Albertelli, M; Crino', Lucio; Colao, A; Ferolla, Piero | |
| Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian Epidemiological study: THE NET MANAGEMENT STUDY | 2012 | Faggiano, A; Ferolla, Piero; Grimaldi, F; Campana, D; Manzoni, M; Davi, Mv; Bianchi, A; Valcavi, R; Papini, E; Giuffrida, D; Ferone, D; Fanciulli, G; Arnaldi, G; Franchi, Gm; Francia, G; Fasola, G; Crino', Lucio; Pontecorvi, L; Tomassetti, P; Colao, A. | |
| Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study | 2012 | Faggiano, A; Ramundo, V; Dicitore, A; Castiglioni, S; Borghi, Mo; Severino, R; Ferolla, Piero; Crino', Lucio; Abbruzzese, A; Sperlongano, P; Caraglia, M; Ferone, D; Hofland, L; Colao, A; Vitale, G. | |
| Evaluation of the different role of 111 In -pentetreotide SPECT/CT of thorax and abdomen in investigating carcinoid tumours | 2013 | Buresta, Tommaso; I., Sabalich; Ferolla, Piero; Tranfaglia, Cristina; Fazzi, Giuseppina; Palumbo, Barbara | |
| Comorbilità di ansia e depressione nei pazienti con tumori carcinoidi - Comorbility between anxiety and depression in patients with carcinoid tumors - | 2013 | Moretti, Patrizia; Dennis, J. L.; Stella, Aldo; Alpini, A.; Cotichelli, P.; Ferolla, Piero; Scarpelli, Giovanni; Quartesan, Roberto; Piselli, M. | |
| LA TERAPIA DEI PROLATTINOMI IN TEMPO DI SPENDING REVIEW. BROMOCRIPTINA vs CABERGOLINA: ANALISI COSTO-EFFICACIA | 2014 | Posati, G.; Carnevale, D.; Scarpelli, Giovanni; Ferolla, Piero; Bini, Vittorio; Angeletti, Gabriella | |
| Postsurgical follow-up is always necessary in bronchial carcinoid | 2014 | Ferolla, Piero; Daddi, N; Puma, Francesco; Crino', Lucio | |
| Survival outcomes and incidence of brain recurrence in high-grade neuroendocrine carcinomas of the lung: Implications for clinical practice | 2016 | Metro, Giulio; Ricciuti, Biagio; Chiari, Rita; Baretti, Marina; Falcinelli, Lorenzo; Giannarelli, Diana; Sidoni, Angelo; Mountzios, Giannis; Crino', Lucio; Bellezza, Guido; Rebonato, Alberto; Ferolla, Piero; Toschi, Luca | |
| Effect of EPA on Neonatal Pig Sertoli Cells “In Vitro”: A Possible Treatment to Help Maintain Fertility in Pre-Pubertal Boys Undergoing Treatment With Gonado-Toxic Therapies | 2021 | Arato, I.; Ceccarelli, V.; Mancuso, F.; Bellucci, C.; Lilli, C.; Ferolla, P.; Perruccio, K.; D'Arpino, A.; Aglietti, M. C.; Calafiore, R.; Cameron, D. F.; Calvitti, M.; Baroni, T.; Vecchini, A.; Luca, G. | |
| Prognostic Significance of Pulmonary Multifocal Neuroendocrine Proliferation With Typical Carcinoid | 2022 | Tassi, V.; Scarnecchia, E.; Ferolla, P.; Mete, O.; Manjula, M.; Allison, F.; Potenza, R.; Vannucci, J.; Ceccarelli, S.; Yasufuku, K.; De Perrot, M.; Pierre, A.; Darling, G.; Colella, R.; Ascani, S.; Mattioli, S.; Keshavjee, S.; Waddell, T. K.; Puma, F.; Daddi, N. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile